These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20175211)

  • 1. Incidental Lewy body disease: clinical comparison to a control cohort.
    Adler CH; Connor DJ; Hentz JG; Sabbagh MN; Caviness JN; Shill HA; Noble B; Beach TG
    Mov Disord; 2010 Apr; 25(5):642-6. PubMed ID: 20175211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease.
    Driver-Dunckley E; Adler CH; Hentz JG; Dugger BN; Shill HA; Caviness JN; Sabbagh MN; Beach TG;
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1260-2. PubMed ID: 25172126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disorders.
    Caviness JN; Adler CH; Hentz JG; Shill HA; Evidente VG; Driver-Dunckley ED; Sabbagh MN; Sue L; Beach TG
    Clin Neurophysiol; 2011 Dec; 122(12):2426-32. PubMed ID: 21616709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
    Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
    Dickson DW; Fujishiro H; DelleDonne A; Menke J; Ahmed Z; Klos KJ; Josephs KA; Frigerio R; Burnett M; Parisi JE; Ahlskog JE
    Acta Neuropathol; 2008 Apr; 115(4):437-44. PubMed ID: 18264713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease.
    Frigerio R; Fujishiro H; Maraganore DM; Klos KJ; DelleDonne A; Heckman MG; Crook JE; Josephs KA; Parisi JE; Boeve BF; Dickson DW; Ahlskog JE
    Arch Neurol; 2009 Sep; 66(9):1114-9. PubMed ID: 19752300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory Dysfunction in Incidental Lewy Body Disease and Parkinson's Disease: An Update.
    Hasan S; Adler CH; Zhang N; Serrano GE; Sue LI; Shill HA; Mehta SH; Beach TG; Driver-Dunckley ED
    Innov Clin Neurosci; 2022; 19(10-12):19-23. PubMed ID: 36591548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.
    Beach TG; Adler CH; Lue L; Sue LI; Bachalakuri J; Henry-Watson J; Sasse J; Boyer S; Shirohi S; Brooks R; Eschbacher J; White CL; Akiyama H; Caviness J; Shill HA; Connor DJ; Sabbagh MN; Walker DG;
    Acta Neuropathol; 2009 Jun; 117(6):613-34. PubMed ID: 19399512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts.
    Caviness JN; Utianski RL; Hentz JG; Beach TG; Dugger BN; Shill HA; Driver-Dunckley ED; Sabbagh MN; Mehta S; Adler CH
    Eur J Neurol; 2016 Feb; 23(2):387-92. PubMed ID: 26518336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced striatal tyrosine hydroxylase in incidental Lewy body disease.
    Beach TG; Adler CH; Sue LI; Peirce JB; Bachalakuri J; Dalsing-Hernandez JE; Lue LF; Caviness JN; Connor DJ; Sabbagh MN; Walker DG
    Acta Neuropathol; 2008 Apr; 115(4):445-51. PubMed ID: 17985144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?
    Frigerio R; Fujishiro H; Ahn TB; Josephs KA; Maraganore DM; DelleDonne A; Parisi JE; Klos KJ; Boeve BF; Dickson DW; Ahlskog JE
    Neurobiol Aging; 2011 May; 32(5):857-63. PubMed ID: 19560232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multi-Organ Distribution of Alpha-Synuclein Pathology in Dementia with Lewy Bodies].
    Wakabayashi K; Miki Y
    Brain Nerve; 2018 May; 70(5):489-500. PubMed ID: 29760287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease.
    Del Tredici K; Hawkes CH; Ghebremedhin E; Braak H
    Acta Neuropathol; 2010 Jun; 119(6):703-13. PubMed ID: 20229352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in cognitive profiles between Lewy body and Parkinson's disease dementia.
    Martini A; Weis L; Schifano R; Pistonesi F; Fiorenzato E; Antonini A; Biundo R
    J Neural Transm (Vienna); 2020 Mar; 127(3):323-330. PubMed ID: 31898759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson disease and incidental Lewy body disease: Just a question of time?
    Iacono D; Geraci-Erck M; Rabin ML; Adler CH; Serrano G; Beach TG; Kurlan R
    Neurology; 2015 Nov; 85(19):1670-9. PubMed ID: 26468408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson's disease dementia.
    Gmitterová K; Gawinecka J; Llorens F; Varges D; Valkovič P; Zerr I
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):461-470. PubMed ID: 30083957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.
    Gnanalingham KK; Byrne EJ; Thornton A; Sambrook MA; Bannister P
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):243-52. PubMed ID: 9069479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presymptomatic Parkinson's disease: the Arizona experience.
    Caviness JN
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S203-6. PubMed ID: 22166435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.